Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Poly-gamma-glutamic Acid (PGA) in fertile women with CIN I
KCT0000733Phase 2Recruiting
- Sponsor
- MOA Life Plus Co. Ltd.
- Start
- Apr 2013
- Modality
- Peptides, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of Poly-gamma-glutamic acid in cervical intraepithelial neoplasia (CIN), sponsored by MOA Life Plus Co. Ltd.. Started Apr 2013; status: recruiting.
02
Drugs
Poly-gamma-glutamic acid
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on KCT0000733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000733.